Results 31 to 40 of about 471,570 (210)

Localized scleroderma secondary to mixed connective tissue disease during abatacept therapy

Journal of Cutaneous Immunology and Allergy, 2022
A 47‐year‐old woman with mixed connective tissue disease was treated with abatacept. After 2 months, a 3‐cm depression with atrophied surface was observed on her back, which had histopathological consistent with the symptoms of localized scleroderma ...
Sayuko Nagaoka, Shujiro Hayashi, Ken Igawa   +2 more
doaj   +1 more source

Hyperpigmented lesions with acquired atrophy following Blaschko lines in a patient with diagnosed with localized scleroderma

Boletín Médico del Hospital Infantil de México, 2021
Background: Linear atrophoderma of Moulin (LAM) is a dermatosis that affects children and adolescents characterized by hyperpigmented and atrophic linear lesions following Blaschko lines. So far, less than 50 cases have been published. Therefore, it is a
Eduardo Marín-Hernández, Belén Suárez-Frías, Alicia G. Siordia Reyes   +2 more
doaj   +1 more source

Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group [PDF]

, 2012
INTRODUCTION: Erectile dysfunction (ED) is common in men with systemic sclerosis (SSc) but the demographics, risk factors and treatment coverage for ED are not well known.
Smith, Vanessa, Alan Tyndall, Garcia de la Peña Lefebvre, Paloma, Edoardo Rosato, Vanessa Smith, Jean Sibilia, Ingo Tarner, Gabriela Riemekasten, Ulrich A. Walker, Walid Abdel Atty Mohamed, Himsel, Andrea, Piotr Wiland, Rednic, Simona, Morović-Vergles, Jadranka, Andrea Himsel, Jose Pereira Da Silva, Allanore, Yannick, Jadranka Morovic Vergles, Anna T. Onken, Starovojtova M. Nikolaevna, Walker, Ulrich A., Farge-Bancel, Dominique, Dominique Farge Bancel, Tarner, Ingo, Mohamed, Walid Ahmed Abdel Atty, Paloma De La Pena Lefebvre, Paolo Airo, Riemekasten, Gabriela, Walker, Ulrich A, Onken, Anna Theresa, Tyndall, Alan, de la Peña Lefebvre, Paloma G., Chingching Foocharoen, Onken, Anna T, Stamenkovic, Bojana, Caramaschi, Paola, Rosato, Edoardo, Airó, Paolo, Dominique Farge-Bancel, Simona Rednic, Wiland, Piotr, Pereira da Silva, José António, Sibilia, Jean, Nikolaevna, Starovojtova M, Paola Caramaschi, Nikolaevna, Starovojtova M., Bojana Stamenkovic, Foocharoen, Chingching, Hachulla, Eric, Thomas Hugle, Distler, Oliver, Ulrich A Walker, Yannick Allanore, Stamenkovic, Bojan, Abdel Atty Mohamed, Walid A., Hügle, Thomas, Jadranka Morović-Vergles, et al, Pereira da Silva, José A., Starovojtova M Nikolaevna, Eric Hachulla, Anna T Onken, Oliver Distler   +62 more
core   +1 more source

Frequency of occurrenceof tumor-associated localized scleroderma

Лечащий Врач
Background. Tumor-associated localized scleroderma is observed among patients with localized scleroderma. It is assumed that the development of this condition may be facilitated by both the inflammatory processes in scleroderma and oncological processes ...
P. O. Kazakova
doaj   +1 more source

The Plastic Surgery for Localized Scleroderma: Progress in Diagnosis and Treatment and Opinions from Peking Union Medical College Hospital

Xiehe Yixue Zazhi, 2022
Localized scleroderma is a rare auto-immune disorder characterized by inflammation and fibrosis of the skin and subcutaneous fat in the affected area, leaving aesthetic impairment to the patients.Such patients often seek plastic surgery for the treatment.
WANG Chenyu, LONG Xiao, ZENG Ang, HUANG Jiuzuo, WANG Xiaojun   +4 more
doaj   +1 more source

Juvenile localized scleroderma: clinical picture, diagnosis, therapeutic update (literature review and own observations)

Zdorovʹe Rebenka, 2019
Among rheumatic diseases in children, a special place belongs to juvenile localized scleroderma, which is highlighted as a separate form in the structure of scleroderma diseases and is characterized by: the onset of the disease up to 16 years, skin ...
L.F. Bogmat, V.V. Nikonova
doaj   +1 more source

Intramuscular Polydeoxyribonucleotides in Fibrotic and Atrophic Localized Scleroderma: An Explorative Prospective Cohort Study

Biomedicines, 2023
Effective options in the quiescent, scantily inflammatory phase of localized scleroderma (morphea) are lacking. A cohort study in patients with histologically confirmed fibroatrophic morphea explored the therapeutic value of the anti-dystrophic A2A ...
Maurizio Romagnuolo, Chiara Moltrasio, Angelo Valerio Marzano, Gianluca Nazzaro, Simona Muratori, Sebastiano Recalcati   +5 more
doaj   +1 more source

Morphea profunda – a case report of deep localized scleroderma with severe thorax deformity

Annales Academiae Medicae Silesiensis
Deep scleroderma is a rare form of limited scleroderma characterised by deep sclerosis that may involve the muscles, fascia, subcutaneous tissue and deep layers of the skin.
Natalia Tekiela, Agnieszka Guberniak, Karina Polak, Bartosz Miziołek, Beata Bergler-Czop   +4 more
doaj   +1 more source

CLINICAL SIGNIFICANCE OF EXTRACORPOREAL PHOTOCHEMOTHERAPY IN COMPLEX TREATMENT OF LOCALIZED SCLERODERMA

Alʹmanah Kliničeskoj Mediciny, 2016
Background: Scleroderma is an autoimmune disease with progressing lesions of connective tissue where fibrosclerotic and vascular disturbances prevail.
O. A. Fomina, A. V. Molochkov, A. V. Kil’dyushevsky   +2 more
doaj   +1 more source

Fat graft and platelet-rich plasma treatment for localized facial scleroderma

Turkish Journal of Plastic Surgery, 2021
Scleroderma is an autoimmune disorder characterized by hardening of the skin on the hands, arms, and face. Immunosuppressors, vasodilators, and physiotherapy are among the treatments for scleroderma. Although these treatments can improve quality of life,
Ali Gokkaya, Dilek Demirez, Metin Gorgu, Ertugrul Karanfil, Jehat Kizilkan, Ali Dogan   +5 more
doaj   +1 more source